Author + information
Sanderson JE. Echocardiography for Cardiac Resynchronization Therapy Selection. J Am Coll Cardiol 2009;53:1960–4.
In this article, there was an error in a calculation under the heading “What Is the Potential Cost of Nonresponders?” on page 1962. The original calculation listed 22,500 people. The correct sentences are below. The author apologizes for this error.
In addition, these 1.5 million nonresponders would have a risk of death at time of implantation of 0.5%, which of 1.5 million nonresponders approximates to 7,500 people. It is possible, therefore, 7,500 people in Europe could die at the time of implantation during a procedure that would have given them no possible clinical benefit in terms of symptoms or functional improvement.
- American College of Cardiology Foundation